1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, December 2016 (p10)

Biopharmaceutical Analysis & Statistics, December 2016 (p10)

24/7 Customer Support

Talk to Veronica

+44 207 0971 241

Publishers

271-300 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

Rheumatoid Arthritis - Pipeline Review, H2 2016

  • € 2273
  • Company report
  • December 2016
  • by Global Markets Direct

Rheumatoid Arthritis - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States, World

Pancreatic Cancer - Pipeline Review, H2 2016

  • € 2273
  • Company report
  • December 2016
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Melanoma - Pipeline Review, H2 2016

  • € 2273
  • Company report
  • December 2016
  • by Global Markets Direct

Melanoma - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Melanoma – Pipeline Review, H2 2016, provides an overview of the Melanoma ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical, Biotechnology
  • Countries : United States, North America

Colorectal Cancer - Pipeline Review, H2 2016

  • € 2273
  • Company report
  • December 2016
  • by Global Markets Direct

Colorectal Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Ovarian Cancer - Pipeline Review, H2 2016

  • € 2273
  • Company report
  • December 2016
  • by Global Markets Direct

Ovarian Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016

  • € 2273
  • Industry report
  • December 2016
  • by GlobalData

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Biopharmaceutical, Biotechnology, Biological Therapy
  • Countries : World

PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report

  • € 159
  • Company report
  • December 2016
  • by MarketLine

Summary PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, ...

  • Industries : Biopharmaceutical
  • Countries : United States

Multiple Sclerosis - Pipeline Review, H2 2016

  • € 2273
  • Company report
  • December 2016
  • by Global Markets Direct

Multiple Sclerosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis – Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology, Mental Health
  • Countries : United States

Breast Cancer - Pipeline Review, H2 2016

  • € 2273
  • Company report
  • December 2016
  • by Global Markets Direct

Breast Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Breast Cancer – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States, North America

Quintiles Transnational Holdings Inc. - Strategy, SWOT and Corporate Finance Report

  • € 159
  • Company report
  • December 2016
  • by MarketLine

Summary Quintiles Transnational Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, ...

  • Countries : United States

Array BioPharma Inc (ARRY) - Financial and Strategic SWOT Analysis Review

  • € 114
  • Company report
  • December 2016
  • by GlobalData

Array BioPharma Inc (ARRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by ...

  • Industries : Biopharmaceutical

Vitro Biopharma (VODG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • December 2016
  • by GlobalData

Summary Vitro Biopharma (Vitro) is a biopharmaceutical company that develops and commercializes adult stem cell products. The company’s products include cell culture media, cell lines, and cell measurement ...

  • Industries : Biopharmaceutical

Port Erin Biopharma Investments Limited

  • € 90
  • Company report
  • December 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Port Erin Biopharma Investments Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biopharmaceutical
  • Countries : United Kingdom

Age Related Macular Degeneration - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • December 2016
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration – Pipeline Review, ...

  • Industries : Pathology, Health Services, Healthcare
  • Countries : United States

Synageva BioPharma Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • December 2016
  • by GlobalData

Summary Synageva BioPharma Corp (Synageva), formerly known as AviGenics, Inc., is a biopharmaceutical company that focuses on discovering, developing and delivering medicines. It offers its products fo ...

  • Industries : Biopharmaceutical, Pharmaceutical

Benitec Biopharma Ltd (BLT) - Financial and Strategic SWOT Analysis Review

  • € 114
  • Company report
  • December 2016
  • by GlobalData

Benitec Biopharma Ltd (BLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by ...

  • Industries : Biopharmaceutical

Prefilled Syringes Market (4th Edition), 2016 - 2026

  • € 2135
  • Industry report
  • December 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION Injectable drug delivery systems have traversed a long way from conventional syringes with vials to prefilled syringes, auto-injectors, pen injectors and needle free systems. These modern ...

  • Industries : Packaging, Manufacturing, Pharmaceutical
  • Countries : World

Metastatic Breast Cancer - Pipeline Review, H2 2016

  • € 2273
  • Company report
  • December 2016
  • by Global Markets Direct

Metastatic Breast Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides ...

  • Industries : Cancer, Pathology
  • Countries : United States

Ophthalmology Drug Development Pipeline Review, 2016

  • € 3632
  • Company report
  • December 2016
  • by GBI Research

Ophthalmology Drug Development Pipeline Review, 2016 Summary Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, ...

  • Industries : Pathology, Health Services, Healthcare
  • Countries : United States

Diabetes & Obesity Drug Development Pipeline Review, 2016

  • € 3632
  • Company report
  • December 2016
  • by GBI Research

Diabetes & Obesity Drug Development Pipeline Review, 2016 Summary The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • € 9995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

  • Industries : Pharmaceutical, Pathology
  • Countries : Japan, World, United States, Asia

Aplastic Anemia - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • November 2016
  • by Global Markets Direct

Aplastic Anemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology
  • Countries : United States

Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • November 2016
  • by Global Markets Direct

Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polyarticular Juvenile Idiopathic ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical, Biopharmaceutical
  • Countries : United States

Metastatic Colorectal Cancer - Pipeline Review, H2 2016

  • € 1818
  • Company report
  • November 2016
  • by Global Markets Direct

Metastatic Colorectal Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Colorectal Cancer – Pipeline Review, H2 ...

  • Industries : Cancer, Pathology
  • Countries : United States

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H2 2016

  • € 3182
  • Company report
  • November 2016
  • by Global Markets Direct

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin ...

  • Industries : Biopharmaceutical, Therapy
  • Countries : United States, World

Shin Nippon Biomedical Laboratories Ltd (2395) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • November 2016
  • by GlobalData

Summary Shin Nippon Biomedical Laboratories Ltd (SNBL) is a healthcare service provider that provides drug and clinical development service to biopharmaceutical companies. Its preclinical services include ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : Japan

Kythera Biopharmaceuticals Inc (KYTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • November 2016
  • by GlobalData

Summary Kythera Biopharmaceuticals Inc (Kythera), a subsidiary of Allergan Plc is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medical aesthetics products. The ...

  • Industries : Biopharmaceutical
  • Countries : United States

Sino Biopharmaceutical Ltd (1177) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • November 2016
  • by GlobalData

Summary Sino Biopharmaceutical Ltd (Sino) is a pharmaceutical company that develops, manufactures and markets Chinese medicines and chemical medicines. The company’s products include kaishi (alprostadil) ...

  • Industries : Pharmaceutical

Oncology drug report - Herceptin - trastuzumab - 2006-2015 analysis; 2016-2021 expectations

  • € 270
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Herceptin (trastuzumab): 2006-2015 analysis; 2016-2021 expectations” is a comprehensive report on the second-largest oncology drug by 2015 sales. Herceptin falls in the monoclonal antibody, HER2 inhibitor, ...

  • Industries : Therapy, Oncology
  • Countries : Europe, Japan, World

MP Biomedicals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • € 227
  • Company report
  • November 2016
  • by GlobalData

Summary MP Biomedicals LLC (MP Biomedicals), formerly ICN Biomedicals is a diagnostic company that manufactures and markets life science, fine chemical and diagnostic products. Its life science products ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.